newsfilter
← Latest News
GlobeNewswire·

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus

HOUSTON, May 11, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending focused on the development of